-
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts
ソース: Buzz FX / 17 11 2024 01:31:19 America/New_York
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 17, 2024 Share Link copied to clipboard. Shares of AnaptysBio, Inc. ( NASDAQ:ANAB - Get Free Report ) have earned a consensus
Read more...